Evolent Health, Inc. EVH Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Evolent Health, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evolent Health, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evolent Health, Inc.'s investing cash flow?
- Evolent Health, Inc. (EVH) reported investing cash flow of -$6.41M in Q1 2026.
- How has Evolent Health, Inc.'s investing cash flow changed year-over-year?
- Evolent Health, Inc.'s investing cash flow increased by 51.1% year-over-year, from -$13.09M to -$6.41M.
- What is the long-term trend for Evolent Health, Inc.'s investing cash flow?
- Over 2 years (2022 to 2024), Evolent Health, Inc.'s investing cash flow has grown at a -50.7% compound annual growth rate (CAGR), from -$259.12M to -$62.93M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.